Effect of etofibrate on bile production in the normolipidemic rat.

dc.centroUniversidad San Pablo-CEU
dc.contributor.authorBocos de Prada, Carlos
dc.contributor.authorOrozco, Enrique
dc.contributor.authorCastro, Mario
dc.contributor.authorQuack, G.
dc.contributor.authorHerrera Castillón, Emilio
dc.date1995-
dc.date.accessioned2011-09-19T15:40:17Z
dc.date.available2011-09-19T15:40:17Z
dc.date.issued1995-09-19T15:40:17Z
dc.descriptionEn: General pharmacology, ISSN 0306-3623, 1995. n. 26, pp 537-542-
dc.description.abstractAbstract~!. The effect of etofibrate, the ethandiol-1,2 diester of nicotinic and clofibric acids on bile production was studied in male rats that received a daily dose of 300 mg of etofibrate/kg body weight by stomach tube for 10 days and were compared with control rats receiving the medium. 2. The bile duct was cannulated, animals were intravenously given I μCi (4- 14C)-cholesterol/100 b.w. and bile was collected at different intervals for a total of 4 hr. 3. Etofibrate treatment decreased plasma cholesterol and triglyceride concentrations and increased the bile flow. The cummulative amount of both bile volume and total bile radioactivity secreted increased linearly in all the animals; the respective slopes being higher in etofibrate treated rats than in controls. 4. The main labelled component found in the bile was always bile acids rather than cholesterol and the proportion of each of these compounds was similar in both groups. Neither was any difference between the groups found in the concentration of bile acids, cholesterol and phospholipids nor in the cholesterol/(bile + phospholipid) ratio. 5. Besides other factors, the present results indicate that an increase in bile flow and biliary cholesterol excretion in its free form and after its conversion into bile acids should contribute to the hypocholesterolemic effect of elofibrateen_EN
dc.formatapplication/pdf-
dc.identifier000000401058-
dc.identifier.urihttp://hdl.handle.net/10637/930
dc.language.isoen-
dc.rights.cchttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rights.licensehttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subjectHypolipidemic drugsen_EN
dc.subjectBile productionen_EN
dc.subjectEtofibrateen_EN
dc.subjectCholesterol excretionen_EN
dc.subjectLithogenic risken_EN
dc.titleEffect of etofibrate on bile production in the normolipidemic rat.-
dc.typeArtículo-
dspace.entity.typePublicationes
europeana.dataProviderUNIVERSIDAD SAN PABLO CEU
europeana.isShownAthttp://hdl.handle.net/10637/930
europeana.objecthttp://repositorioinstitucional.ceu.es/visor/libros/401058/thumb_europeana/401058.jpg
europeana.providerHispana
europeana.rightshttp://creativecommons.org/publicdomain/zero/1.0/
europeana.typeTEXT
relation.isAuthorOfPublicationaa357baa-d71a-431b-b1ce-6007bcceabf9
relation.isAuthorOfPublication05ccc1aa-254e-4ec7-a482-2b9e70f018b4
relation.isAuthorOfPublication.latestForDiscoveryaa357baa-d71a-431b-b1ce-6007bcceabf9

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Effect_Bocos_et_al_Gen_Pharmac_1995.pdf
Size:
389.56 KB
Format:
Adobe Portable Document Format